MILWAUKEE, Jan. 19, 2022 /PRNewswire/ -- Ademi LLP is investigating Zogenix (NASDAQ: ZGNX) for possible breaches of fiduciary duty and other violations of law in its transaction with UCB. 

Click here to learn how to join the action: https://www.ademilaw.com/case/zogenix-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

Ademi LLP alleges Zogenix's financial outlook and prospects are excellent and yet Zogenix shareholders will receive only $26.00 in cash at closing, plus a contingent value right for a potential cash payment of $2.00 upon satisfaction of certain conditions. The merger agreement unreasonably limits competing bids for Zogenix by prohibiting solicitation of further bids, and imposing a significant penalty if Zogenix accepts a superior bid. Zogenix insiders will receive substantial benefits as part of change of control arrangements.

We are investigating the conduct of Zogenix's board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Zogenix.

If you own Zogenix common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or https://www.ademilaw.com/case/zogenix-inc.                        

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-ademi-llp-investigates-whether-zogenix-inc-has-obtained-a-fair-price-in-its-transaction-with-ucb-301464073.html

SOURCE Ademi LLP